After an 80-year gap, human trials of a new tuberculosis vaccine are due to
start. If the vaccine is successful it could save millions of lives each year.
TB jabs use a weakened form of the bacterium that causes the disease in
cows—Bacille Calmette-Guérin. BCG gives good protection for about
10 years but then it wears off, and booster shots have little effect. Now Helen
McShane at the John Radcliffe Hospital in Oxford is starting trials with a
modified cowpox virus that carries a TB antigen. Used as a booster after BCG,
the new vaccine should give a…
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Health
Woman with Alzheimer's starts conversing again after taking psilocybin
News
Life
New-to-science spider builds trap that flings ants into the air
News
Health
How menopause radically changes the brain – and what happens after
Features
Mind
‘Fusogenic’ neurosurgery let paralysed pigs walk again – are we next?
Comment
Popular articles
Trending Â鶹´«Ã½ articles
1
How menopause radically changes the brain – and what happens after
2
Faecal transplant makes the brains of old mice act young again
3
Woman with Alzheimer's starts conversing again after taking psilocybin
4
‘Fusogenic’ neurosurgery let paralysed pigs walk again – are we next?
5
A promising natural technique to remove CO2 could backfire
6
A quantum state that lasts forever may finally be within our grasp
7
The secrets to keeping your brain sharp in old age
8
People training new AI models admit they just get chatbots to do it
9
New-to-science spider builds trap that flings ants into the air
10
We've found a mysterious substance on Titan and Pluto
